APA (7th ed.) Citation

I, N., G, R., JC, C., A, C., K, T., EA, A., . . . GH, G. (2012). Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 156(10), 710.

Chicago Style (17th ed.) Citation

I, Neumann, Rada G, Claro JC, Carrasco-Labra A, Thorlund K, Akl EA, Bates SM, and Guyatt GH. "Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-analysis." Annals of Internal Medicine 156, no. 10 (2012): 710.

MLA (9th ed.) Citation

I, Neumann, et al. "Oral Direct Factor Xa Inhibitors Versus Low-Molecular-Weight Heparin to Prevent Venous Thromboembolism in Patients Undergoing Total Hip or Knee Replacement: A Systematic Review and Meta-analysis." Annals of Internal Medicine, vol. 156, no. 10, 2012, p. 710.